Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Loxo Oncology, Inc. (LOXO)

« Back to company index

LOXO Chatter Timeline

Stock Ticker for LOXO

Most Active Tweeters for LOXO

UserTweets
@matthewherper 1
@StevElms 1
@christymaginn 1
@HenryJOncology 1
@Gambiste1 1

Recent Tweets for LOXO

Gambiste1 @Gambiste1
RT @HenryJOncology: The $LOXO $LLY @FDAOncology presentation is worth a read. 1 tumor agnostic issues 2 NGS 3 Government #biotech policy h…
December 6th 2019, 8:12pm
HenryJOncology @HenryJOncology
The $LOXO $LLY @FDAOncology presentation is worth a read. 1 tumor agnostic issues 2 NGS 3 Government #biotech polic… https://t.co/JGCKFFACr3
December 6th 2019, 8:12pm
christymaginn @christymaginn
RT @matthewherper: At $LLY, Josh and Jake are taking over. Lilly putting $LOXO in charge of all early drug development. Here's the story of…
December 5th 2019, 11:12am
StevElms @StevElms
@DHymanMD Great to see that the talented and focused $LOXO team will stay together to create even more exceptional… https://t.co/ayPw5oDjMC
December 5th 2019, 10:12am
matthewherper @matthewherper
At $LLY, Josh and Jake are taking over. Lilly putting $LOXO in charge of all early drug development. Here's the sto… https://t.co/GWudMim6qR
December 5th 2019, 6:12am
BursatilBiotech @BursatilBiotech
@NedPagliarulo What about $LOXO?
November 21st 2019, 9:11am
joaquinkam @joaquinkam
@NYYash It is trading in zombie mode. Like $loxo weeks before acquisition
November 12th 2019, 5:11pm
XBIObserver @XBIObserver
@Ogut_Ozgur Every time $loxo doses a patient 10+ bioturd startups are obliterated
November 7th 2019, 11:11am
Ogut_Ozgur @Ogut_Ozgur
@XBIObserver Every time $loxo doses a patient, a competitor loses their portfolio.
November 7th 2019, 11:11am
XBIObserver @XBIObserver
@BiotechObserver @Ogut_Ozgur $LOXO The Chuck Norris of selective and tumor agnostic oncology medications.
November 7th 2019, 11:11am
XBIObserver @XBIObserver
@Ogut_Ozgur OMG I've heard that when $LOXO doses a patient, they just get up and walk the cancer off. BOOM
November 7th 2019, 11:11am
Ogut_Ozgur @Ogut_Ozgur
@XBIObserver I heard $loxo dosed a patient! Plus, they’ve clearly won the google search race. $arql is dead. I’m s… https://t.co/pfiYDdK00o
November 7th 2019, 11:11am
BiotechObserver @BiotechObserver
@twhitfill Is the market assumption here that $LOXO drug will maintain a 100% response rate as sample size goes up… https://t.co/VB0D0P6YpV
November 7th 2019, 11:11am
LuciusJameson @LuciusJameson
@twhitfill At least $Loxo BTKi is the only drug in their pipeline not made by the “Co-Crystal CRO” $Arry... so… https://t.co/Y0O3BoM3Nf
November 6th 2019, 11:11pm
joaquinkam @joaquinkam
$PTLA non sense price action reminds me $loxo price action few weeks before acquisition. Good pipeline. Buying… https://t.co/JqVwSV6gO6
November 6th 2019, 12:11pm
joaquinkam @joaquinkam
@Rajt1111 Time to buy . Huge bounce around the corner. $ptla could be acquired sooner than expected $loxo same pri… https://t.co/9NAEHMvuA9
November 6th 2019, 11:11am
HenryJOncology @HenryJOncology
What predictive model did $LLY use to think that this was a good idea? This is why I liked $loxo as a stand-alone. https://t.co/RW5ZoS54ld
October 16th 2019, 8:10pm
lblegend33 @lblegend33
@_B_I_O_T_E_C_H_ Said the same thing when Bayer partnered w $loxo
October 16th 2019, 8:10am
StevElms @StevElms
So proud of the $LOXO team continuing to provide therapies for cancer patients. https://t.co/Sy9Krd25Ve
September 29th 2019, 6:09pm
GautschiOliver @GautschiOliver
@VivekSubbiah Big credit to Michael Rothenberg. Very impressed by the drug and the people behind it $LOXO
September 29th 2019, 3:09pm
BigChodu @BigChodu
@melty1 @srqstockpicker $loxo buyout started that explosive run
September 26th 2019, 2:09pm
StockTipRobot @StockTipRobot
My robot friend Sergei (who is totally not a Russian bot) says to exit Loxo Oncology $LOXO #StockMarket
September 24th 2019, 8:09pm
StockTipRobot @StockTipRobot
Rigorous analysis I didn't conduct says to buy, sell, and hold Loxo Oncology $LOXO #JustSaying
September 21st 2019, 1:09am
JunkieBiotech @JunkieBiotech
@matthewherper Good for Josh and Jake. I passed on so many rounds of funding and each time it was a bad decision. $lly $loxo
September 9th 2019, 11:09pm
SlingshotCtlyst @SlingshotCtlyst
Selpercatinib (LOXO-292) shows a 68 Percent Objective Response Rate and Sustained Durability in Heavil $LLY , $LOXO https://t.co/TSs65YDcR6
September 9th 2019, 10:09am
BioDueDiligence @BioDueDiligence
RT @BursatilBiotech: First time: is luck Second time: you're getting good. More than 3 times: you're definitely good. Nice job, $LOXO $L…
September 9th 2019, 8:09am
BursatilBiotech @BursatilBiotech
First time: is luck Second time: you're getting good. More than 3 times: you're definitely good. Nice job, $LOXO… https://t.co/kVvLtLAWSV
September 9th 2019, 7:09am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.